NSTEMI is considered a heart attack. ST-elevation myocardial infarction (STEMI) is the most serious type of ACS. When an ECG shows ST-elevation, someone is having a "massive" heart attack. ST-segment ...

A heart attack is a potentially life-threatening medical emergency that can lead to cardiac arrest or death. Heart attacks ...

A heart-themed exhibition showcasing the evolution of cardiology in China and the stories of Dr Chen Haozhu, acknowledged as ...

A study uncovers IL-1β signaling in cardiac fibrosis, highlighting distinct fibroblast populations and promising ...

Among patients with polycythemia vera, the treatment pairing of Jakafi and Pegasys shows benefits with acceptable toxicity, ...

Topline results were announced from a cardiovascular outcomes study evaluating oral semaglutide in patients with type 2 diabetes.

Scientists say their findings could have broader implications for understanding tissue repair in other organs.

In Novo Nordisk’s randomized clinical trial, semaglutide reduced the risk for major adverse cardiovascular events by 14% ...

Novo Nordisk today announced the headline results from the SOUL cardiovascular outcomes trial. The double-blinded, randomized ...

The global creatine kinase reagent market, valued at approximately USD 296.2 million at the end of 2021, is poised for substantial growth, with projections indicating a compound annual growth rate ...

Discover how Novo Nordisk's GLP-1 medication, Rybelsus, reduces major adverse cardiovascular events by 14% in a phase 3 trial, with plans for an expanded label.